In brief
In a deferred prosecution agreement, McKinsey's financial penalty underscores ongoing scrutiny of the firm’s practices.
McKinsey & Co. has consented to pay over $122 million to settle federal bribery allegations tied to its operations in South Africa, as disclosed by prosecutors in New York on Thursday. This settlement occurs against the backdrop of substantial financial settlements the firm has faced in recent years, including about $1 billion related to its involvement with opioid producers.The aforementioned fine represents an element of a deferred prosecution agreement, which stipulates that the bribery charge against McKinsey will be dropped after a three-year period if the company adheres to the deal's terms. Adding to the situation, Vikas Sagar, a former senior partner and head of McKinsey's Johannesburg office, has pleaded guilty to charges related to conspiracy against anti-corruption laws.The investigation into McKinsey’s conduct relates to consulting work performed for two South African state-owned entities over a decade ago. These companies include one managing the country's electric generation operations and another overseeing the freight rail and port systems. Prosecutors allege that confidential information leading to lucrative contracts was exchanged for bribes directed at two influential officials, resulting in profits exceeding $85 million for McKinsey.Damian Williams, U.S. Attorney for the Southern District of New York, stated that McKinsey Africa engaged in a years-long scheme to bribe government officials in South Africa. A 2018 report by The New York Times highlighted these controversial contracts, marking a significant blemish on the firm's nearly century-long legacy. In the following year, McKinsey’s role in intensifying sales for Purdue Pharma, the manufacturer of OxyContin amid an ongoing opioid crisis, captured public attention, marking the company as a target of further federal investigations.
